Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.46
-0.01 (-0.18%)
Mar 4, 2026, 4:00 PM EST - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 251.00K | 33.49M | 4.93M | 2.00M | - | |
| -99.25% | 579.21% | 146.30% | - | - | |
| 251.00K | 33.49M | 4.93M | 2.00M | - | |
| -99.25% | 579.21% | 146.30% | - | - | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 251.00K | 33.49M | 4.93M | 2.00M | - | |
| -99.25% | 579.21% | 146.30% | - | - | |
| 251.00K | 33.49M | 4.93M | 2.00M | - | |
| -99.25% | 579.21% | 146.30% | - | - | |
Source: S&P Global Market Intelligence.